Dysregulation of Survivin-Targeting MicroRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Mar 21

PMID 35309327

Authors

Navid Shomali

Marwah Suliman Maashi

Behzad Baradaran

Amin Daei Sorkhabi

Aila Sarkesh

Hamed Mohammadi

Maryam Hemmatzadeh

Faroogh Marofi

Siamak Sandoghchian Shotorbani

Mostafa Jarahian

Affiliations

Soon will be listed here.

Abstract

It has been well established that the etiopathogenesis of diverse autoimmune diseases is rooted in the autoreactive immune cells' excessively proliferative state and impaired apoptotic machinery. Survivin is an anti-apoptotic and mitotic factor that has sparked a considerable research interest in this field. Survivin overexpression has been shown to contribute significantly to the development of autoimmune diseases autoreactive immune cell overproliferation and apoptotic dysregulation. Several microRNAs (miRNAs/miRs) have been discovered to be involved in survivin regulation, rendering the survivin-miRNA axis a perspective target for autoimmune disease therapy. In this review, we discuss the role of survivin as an immune regulator and a highly implicated protein in the pathogenesis of autoimmune diseases, the significance of survivin-targeting miRNAs in autoimmunity, and the feasibility of targeting the survivin-miRNA axis as a promising therapeutic option for autoimmune diseases.

Citing Articles

Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice.

Daei Sorkhabi A, Komijani E, Sarkesh A, Shadbad P, Aghebati-Maleki A, Aghebati-Maleki L Cell Commun Signal. 2023; 21(1):321.

PMID: 37946301 PMC: 10634124. DOI: 10.1186/s12964-023-01289-9.

MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy.

Aleshcheva G, Baumeier C, Harms D, Bock C, Escher F, Schultheiss H ESC Heart Fail. 2023; 10(6):3410-3418.

PMID: 37679968 PMC: 10682862. DOI: 10.1002/ehf2.14523.

Current status of skin cancers with a focus on immunology and immunotherapy.

Khayyati Kohnehshahri M, Sarkesh A, Mohamed Khosroshahi L, HajiEsmailPoor Z, Aghebati-Maleki A, Yousefi M Cancer Cell Int. 2023; 23(1):174.

PMID: 37605149 PMC: 10440946. DOI: 10.1186/s12935-023-03012-7.

Oleuropein as An Effective Suppressor of Inflammation and MicroRNA-146a Expression in Patients with Rheumatoid Arthritis.

Mahi H, Yousefi Z, Toufan F, Yarmohammadi M, Jafarisani M, Eskandari N Cell J. 2023; 25(7):505-512.

PMID: 37543863 PMC: 10404353. DOI: 10.22074/cellj.2023.1989941.1237.

miR-142-3p encapsulated in T lymphocyte-derived tissue small extracellular vesicles induces Treg function defect and thyrocyte destruction in Hashimoto's thyroiditis.

Li G, He L, Huang J, Liu J, Chen W, Zhong J BMC Med. 2023; 21(1):206.

PMID: 37280674 PMC: 10242775. DOI: 10.1186/s12916-023-02914-7.

References

Yang Z, Chen Z, Wang C, Huang P, Luo M, Zhou R . STAT3/SH3PXD2A-AS1/miR-125b/STAT3 positive feedback loop affects psoriasis pathogenesis via regulating human keratinocyte proliferation. Cytokine. 2021; 144:155535. DOI: 10.1016/j.cyto.2021.155535. View

Tsokos G, Lo M, Reis P, Sullivan K . New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016; 12(12):716-730. DOI: 10.1038/nrrheum.2016.186. View

Albanesi C, De Pita O, Girolomoni G . Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007; 25(6):581-8. DOI: 10.1016/j.clindermatol.2007.08.013. View

Guha M, Plescia J, Leav I, Li J, Languino L, Altieri D . Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009; 69(12):4954-8. PMC: 2718425. DOI: 10.1158/0008-5472.CAN-09-0584. View

Galeotti L, Adrian K, Berg S, Tarkowski A, Bokarewa M . Circulating survivin indicates severe course of juvenile idiopathic arthritis. Clin Exp Rheumatol. 2008; 26(2):373-8. View

Tamm I, Wang Y, Sausville E, Scudiero D, Vigna N, Oltersdorf T . IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998; 58(23):5315-20. View

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

Evangelatos G, Fragoulis G, Koulouri V, Lambrou G . MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmun Rev. 2019; 18(11):102391. DOI: 10.1016/j.autrev.2019.102391. View

Chen Y, Tsai Y, Tseng S . Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway. Surgery. 2012; 153(1):4-16. DOI: 10.1016/j.surg.2012.03.030. View

10.

Zhang Y, Zhou S, Yan H, Xu D, Chen H, Wang X . miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Sci Rep. 2016; 6:19995. PMC: 4742816. DOI: 10.1038/srep19995. View

11.

Ebrahimiyan H, Rezaei N, Vojdanian M, Aslani S, Jamshidi A, Mahmoudi M . microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int J Rheum Dis. 2019; 22(6):1107-1114. DOI: 10.1111/1756-185X.13520. View

12.

Song J, So T, Cheng M, Tang X, Croft M . Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity. 2005; 22(5):621-31. DOI: 10.1016/j.immuni.2005.03.012. View

13.

Gravina G, Wasen C, Garcia-Bonete M, Turkkila M, Erlandsson M, Toyra Silfversward S . Survivin in autoimmune diseases. Autoimmun Rev. 2017; 16(8):845-855. DOI: 10.1016/j.autrev.2017.05.016. View

14.

Chettiar S, Cooley J, Park I, Bhasin D, Chakravarti A, Li P . Design, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle. Bioorg Med Chem Lett. 2013; 23(19):5429-33. DOI: 10.1016/j.bmcl.2013.07.034. View

15.

Nogueira-Ferreira R, Vitorino R, Ferreira-Pinto M, Ferreira R, Henriques-Coelho T . Exploring the role of post-translational modifications on protein-protein interactions with survivin. Arch Biochem Biophys. 2013; 538(2):64-70. DOI: 10.1016/j.abb.2013.07.027. View

16.

Song J, So T, Croft M . Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol. 2008; 180(11):7240-8. PMC: 2410213. DOI: 10.4049/jimmunol.180.11.7240. View

17.

Li D, Hu C, Li H . Survivin as a novel target protein for reducing the proliferation of cancer cells. Biomed Rep. 2018; 8(5):399-406. PMC: 5920485. DOI: 10.3892/br.2018.1077. View

18.

Kusner L, Ciesielski M, Marx A, Kaminski H, Fenstermaker R . Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS One. 2014; 9(7):e102231. PMC: 4106794. DOI: 10.1371/journal.pone.0102231. View

19.

Albanesi C, Madonna S, Gisondi P, Girolomoni G . The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis. Front Immunol. 2018; 9:1549. PMC: 6043636. DOI: 10.3389/fimmu.2018.01549. View

20.

Huang W, Tsai Y, Chen S, Kuo C, Kuo Y, Lee K . HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells. Front Pharmacol. 2018; 8:902. PMC: 5736991. DOI: 10.3389/fphar.2017.00902. View